Global Colonic Stent Market Growth 2026-2032
The global Colonic Stent market size is predicted to grow from US$ 258 million in 2025 to US$ 400 million in 2032; it is expected to grow at a CAGR of 6.3% from 2026 to 2032.
Colonic Stent refers to an endoluminal implant used to restore patency in an obstructed or stenotic colon or rectum. The market primarily covers self-expanding metal stents manufactured from braided nitinol wire and supplied preloaded in endoscopic and fluoroscopic delivery systems. Products are available as uncovered, partially covered and fully covered configurations, although uncovered stents constitute the established design for malignant colorectal obstruction because tissue contact improves anchoring and reduces migration. Key specifications include stent body and flare diameter, expanded length, delivery-system profile and working length, guidewire compatibility, radial and axial force, flexibility, foreshortening, radiopacity, migration resistance, recapturability and deployment accuracy. Commercial body diameters commonly include approximately 18–25 mm, while expanded lengths generally span approximately 60–120 mm, depending on manufacturer and model. Principal applications include palliation of malignant colonic obstruction, decompression as a bridge to elective surgery and carefully selected treatment of benign strictures or postoperative complications.
Key Findings
In 2025, global Colonic Stent production reached approximately 177 K Units, with an average global market price of around US$ 1,489 per unit.
Uncovered nitinol SEMS constitute the principal commercial colonic stent configuration
Malignant colorectal obstruction forms the core clinical demand base
Palliative treatment and bridge to surgery are the two major treatment objectives
Flexible low-profile delivery systems improve access through tortuous colorectal anatomy
Competition combines multinational endoscopy companies with Korean, European and Chinese specialists
Market Trends
Colonic stents are evolving toward more flexible, lower-profile and accurately deployable systems designed for tortuous colorectal anatomy. Manufacturers are optimizing the balance between radial force required to open malignant strictures and axial force that can contribute to pain, wall pressure or perforation. Smaller delivery systems capable of passing through therapeutic endoscope channels are improving access to tight lesions, while controlled release, partial recapture and clear endoscopic or radiopaque markers support more accurate placement. Atraumatic ends, flared geometries and refined mesh cells are being used to improve anchoring and reduce tissue injury. Uncovered stents remain central to malignant obstruction, but covered and partially covered products continue to be evaluated for selected benign strictures, postoperative leaks and fistulas where removability or sealing is required. Clinical decision-making is becoming more indication-specific, with clearer differentiation between palliative decompression and bridge-to-surgery use. Hospitals increasingly assess not only technical deployment success but also migration, perforation, re-obstruction, emergency surgery, stoma avoidance and subsequent surgical outcomes. The long-term direction is toward anatomy-adaptive force profiles, predictable deployment and stronger procedure support.
Market Dynamics
Drivers
Demand is driven primarily by colorectal cancer and other pelvic or abdominal malignancies that cause intrinsic stenosis or external compression of the large bowel. Colonic stenting can rapidly decompress an obstructed colon, restore bowel continuity and relieve symptoms without immediate open surgery in appropriately selected patients. In palliative care, stents can avoid or delay colostomy and support subsequent chemotherapy or supportive treatment. In bridge-to-surgery pathways, successful decompression may convert an emergency presentation into a planned operation after physiological stabilization and bowel preparation. Population aging, rising colorectal cancer diagnosis and wider availability of therapeutic colonoscopy increase the addressable patient pool. Improvements in endoscopic imaging, guidewires, fluoroscopic navigation and low-profile delivery systems also allow physicians to manage tighter and more anatomically difficult strictures. Multidisciplinary coordination among gastroenterologists, colorectal surgeons, oncologists and interventional radiologists supports more standardized case selection.
Restraints
Clinical adoption is constrained by perforation, migration, re-obstruction, tumor ingrowth or overgrowth, bleeding, pain, tenesmus and stent-related technical failure. Perforation is particularly important because it can necessitate emergency surgery and may affect subsequent oncological management. The risk profile varies with lesion length and location, complete versus partial obstruction, bowel-wall condition, previous radiotherapy, stent dimensions and operator experience. Uncovered products provide stronger anchoring but may develop tumor ingrowth, while covered products reduce ingrowth and can support removal but generally carry greater migration risk. Stenting may be difficult in very distal rectal lesions, sharply angulated segments or strictures that cannot be traversed safely by a guidewire. Emergency surgery, diverting stoma, surgical resection and conservative management remain alternatives. Regional guidelines, reimbursement policies and hospital capabilities also influence adoption, particularly for bridge-to-surgery use.
Opportunities
The largest opportunities lie in low-profile through-the-scope systems, controlled-release platforms and stents engineered for sigmoid flexures and other tortuous colorectal segments. Products with lower axial force, adequate radial support and minimal foreshortening can improve conformability and deployment predictability. Longer size ranges and precise marker systems can support treatment of irregular or extended lesions. Re-obstruction caused by tumor ingrowth creates opportunities for refined mesh structures and selected stent-in-stent procedures. Covered removable products may address carefully selected benign anastomotic strictures, leaks and fistulas if migration can be controlled and removal protocols are established. Emerging markets offer additional demand as colorectal cancer screening, diagnosis and therapeutic endoscopy expand. Manufacturers can strengthen differentiation by providing physician training, simulation, procedural guidance, rapid technical support and complete accessories. Prospective evidence defining appropriate bridge-to-surgery populations and longer-term oncological outcomes can also expand confidence in standardized use.
Challenges
The central engineering challenge is balancing radial force, axial flexibility, anchoring and atraumatic contact with a thin and sometimes compromised colonic wall. Excessive force may increase pressure injury and perforation, whereas inadequate expansion can result in persistent obstruction or early re-occlusion. High flexibility facilitates navigation but may reduce pushability or deployment control. Stents can foreshorten during expansion, requiring careful lesion measurement and sufficient margins. Severe obstruction may prevent guidewire passage, and the final stent position can be affected by bowel angulation and peristalsis. Clinical comparison is complicated because palliative patients and bridge-to-surgery patients have different endpoints, treatment pathways and follow-up periods. Manufacturers must maintain consistent nitinol properties, mesh geometry, flare dimensions, radiopaque-marker placement, delivery-catheter performance, sterilization and package integrity. Regulatory requirements and purchasing pressure further raise the cost of maintaining a broad size portfolio while meeting quality and clinical-support expectations.
Industry Chain Analysis
The upstream chain includes medical-grade nitinol wire, radiopaque marker materials such as tantalum or platinum alloys, polymer catheters, guidewire-compatible components, delivery handles, lubricious coatings and sterilization services. Manufacturing involves wire preparation and braiding, heat setting, surface treatment, electropolishing, formation of flared or atraumatic ends, marker assembly, optional membrane application, delivery-system loading, packaging and sterilization validation. Midstream value is generated through stent geometry, radial and axial force control, flexibility, foreshortening management, migration resistance, recapture capability and production consistency. Finished systems reach hospitals through manufacturers’ direct sales teams, endoscopy-platform companies and specialized distributors. Downstream users include gastroenterology and endoscopy departments, colorectal surgery units, cancer centers and interventional radiology teams. Value creation extends beyond the implant to clinical evidence, regulatory registration, physician training, procedural support, inventory availability, quality traceability and post-market surveillance. Reliable access to multiple diameters and lengths is important because lesion anatomy varies considerably.
Segment Insights
Uncovered products allow the mesh to contact the bowel wall directly, providing stronger anchoring and reducing migration; they are the established configuration for malignant colorectal obstruction but remain susceptible to tumor ingrowth. Partially covered products seek to combine anchoring at uncovered sections with ingrowth control across the covered body. Fully covered products can reduce tissue ingrowth, support sealing and facilitate removal, but migration is a significant design and clinical limitation. Consequently, covered products occupy more selective applications than uncovered stents.
Further segmentation should include body diameter, expanded length, delivery profile and deployment technology. Commercial body diameters commonly fall into ≤20 mm, 21–24 mm and ≥25 mm groups, while lengths can be classified as ≤60 mm, 61–90 mm and more than 90 mm. Common commercial sizes include 18, 20, 22 and 25 mm diameters and 60–120 mm lengths. Products may also be segmented into conventional release and controlled-release or recapturable systems, as well as through-the-scope and guidewire-guided configurations. These numerical and technical dimensions provide a stronger purchasing-oriented framework than covering structure alone.
Downstream Market Opportunities
Application analysis should separate disease etiology from treatment intent to avoid double counting. By disease, the primary categories are malignant colonic stenosis and obstruction, benign colonic stricture, postoperative anastomotic leakage or fistula, and other conditions. By treatment intent, malignant cases can be divided into palliative treatment and bridge to surgery. “Palliative Treatment” is the correct English term; “Patient Treatment” should not be used. Palliative stenting is intended to relieve obstruction in patients with unresectable disease or those unsuitable for surgery. Bridge-to-surgery placement provides temporary decompression before planned resection in appropriately selected patients. Benign strictures, including selected anastomotic, inflammatory or radiation-related cases, form a smaller and more cautious application field because long-term placement, migration and removal require careful management.
Regional Insights
North America and Europe are mature markets with established colorectal cancer pathways, therapeutic-endoscopy infrastructure and formal clinical guidance. Boston Scientific and Cook Medical have broad hospital access and dedicated colonic stent platforms. European specialists including ENDO-FLEX, Leufen Medical and ELLA-CS participate through gastrointestinal stent portfolios, although product-level availability and indications vary by country. Regional adoption is influenced by colorectal-surgery practice, reimbursement, access to experienced endoscopists and differences in bridge-to-surgery recommendations. Clinical evidence, delivery accuracy and adverse-event reduction carry greater weight than price alone in advanced markets.
South Korea is an important specialist manufacturing base. M.I.Tech, Taewoong Medical and Sewoon Medical provide gastrointestinal stent technologies and multiple enteral configurations. Taewoong Medical is an important omission from the initial list and should be included in the expanded manufacturer pool. Japan has a sophisticated endoscopy market and strong distribution capabilities; Olympus supplies selected colonic stents manufactured by M.I.Tech and should be classified as a product provider or distributor rather than the independent manufacturing source of those devices. China is expanding through Micro-Tech Endoscopy, Jiangsu Vedkang and other domestic gastrointestinal-device manufacturers. T?rkiye and other emerging regions participate through INVAMED and additional suppliers, subject to product registration and current manufacturing verification.
Competitive Landscape Analysis
The competitive landscape combines multinational endoscopy companies with specialized Asian and European stent manufacturers. Boston Scientific competes through the WallFlex colonic platform, multiple diameters and lengths, lower-profile variants and broad international hospital access. Cook Medical offers the Evolution controlled-release uncovered colonic stent, emphasizing deployment control, recapture and navigation through difficult anatomy. M.I.Tech is the manufacturing source of relevant HANAROSTENT colonic products supplied by Olympus in certain markets, so the two companies should not be counted as separate manufacturers for those devices. Taewoong Medical should be added to the core or extended enterprise pool because its Niti-S portfolio includes uncovered, fully covered, end-bare, both-bare and composite colonic stent configurations. Micro-Tech Endoscopy offers colonic and rectal stents with multiple diameters, lengths and covering structures and represents an important Chinese international supplier. ENDO-FLEX, Leufen Medical, ELLA-CS, Sewoon Medical, INVAMED and Jiangsu Vedkang form the broader specialist pool, subject to current product registration and regional availability. Competition centers on force balance, flexibility, migration resistance, delivery profile, release control, clinical evidence, physician access and reliable supply rather than unsupported overall rankings.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Colonic Stent Industry Forecast” looks at past sales and reviews total world Colonic Stent sales in 2025, providing a comprehensive analysis by region and market sector of projected Colonic Stent sales for 2026 through 2032. With Colonic Stent sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Colonic Stent industry.
This Insight Report provides a comprehensive analysis of the global Colonic Stent landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Colonic Stent portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Colonic Stent market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Colonic Stent and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Colonic Stent.
This report presents a comprehensive overview, market shares, and growth opportunities of Colonic Stent market by product type, application, key manufacturers and key regions and countries.
Market Segmentation
Colonic Stent refers to an endoluminal implant used to restore patency in an obstructed or stenotic colon or rectum. The market primarily covers self-expanding metal stents manufactured from braided nitinol wire and supplied preloaded in endoscopic and fluoroscopic delivery systems. Products are available as uncovered, partially covered and fully covered configurations, although uncovered stents constitute the established design for malignant colorectal obstruction because tissue contact improves anchoring and reduces migration. Key specifications include stent body and flare diameter, expanded length, delivery-system profile and working length, guidewire compatibility, radial and axial force, flexibility, foreshortening, radiopacity, migration resistance, recapturability and deployment accuracy. Commercial body diameters commonly include approximately 18–25 mm, while expanded lengths generally span approximately 60–120 mm, depending on manufacturer and model. Principal applications include palliation of malignant colonic obstruction, decompression as a bridge to elective surgery and carefully selected treatment of benign strictures or postoperative complications.
Key Findings
In 2025, global Colonic Stent production reached approximately 177 K Units, with an average global market price of around US$ 1,489 per unit.
Uncovered nitinol SEMS constitute the principal commercial colonic stent configuration
Malignant colorectal obstruction forms the core clinical demand base
Palliative treatment and bridge to surgery are the two major treatment objectives
Flexible low-profile delivery systems improve access through tortuous colorectal anatomy
Competition combines multinational endoscopy companies with Korean, European and Chinese specialists
Market Trends
Colonic stents are evolving toward more flexible, lower-profile and accurately deployable systems designed for tortuous colorectal anatomy. Manufacturers are optimizing the balance between radial force required to open malignant strictures and axial force that can contribute to pain, wall pressure or perforation. Smaller delivery systems capable of passing through therapeutic endoscope channels are improving access to tight lesions, while controlled release, partial recapture and clear endoscopic or radiopaque markers support more accurate placement. Atraumatic ends, flared geometries and refined mesh cells are being used to improve anchoring and reduce tissue injury. Uncovered stents remain central to malignant obstruction, but covered and partially covered products continue to be evaluated for selected benign strictures, postoperative leaks and fistulas where removability or sealing is required. Clinical decision-making is becoming more indication-specific, with clearer differentiation between palliative decompression and bridge-to-surgery use. Hospitals increasingly assess not only technical deployment success but also migration, perforation, re-obstruction, emergency surgery, stoma avoidance and subsequent surgical outcomes. The long-term direction is toward anatomy-adaptive force profiles, predictable deployment and stronger procedure support.
Market Dynamics
Drivers
Demand is driven primarily by colorectal cancer and other pelvic or abdominal malignancies that cause intrinsic stenosis or external compression of the large bowel. Colonic stenting can rapidly decompress an obstructed colon, restore bowel continuity and relieve symptoms without immediate open surgery in appropriately selected patients. In palliative care, stents can avoid or delay colostomy and support subsequent chemotherapy or supportive treatment. In bridge-to-surgery pathways, successful decompression may convert an emergency presentation into a planned operation after physiological stabilization and bowel preparation. Population aging, rising colorectal cancer diagnosis and wider availability of therapeutic colonoscopy increase the addressable patient pool. Improvements in endoscopic imaging, guidewires, fluoroscopic navigation and low-profile delivery systems also allow physicians to manage tighter and more anatomically difficult strictures. Multidisciplinary coordination among gastroenterologists, colorectal surgeons, oncologists and interventional radiologists supports more standardized case selection.
Restraints
Clinical adoption is constrained by perforation, migration, re-obstruction, tumor ingrowth or overgrowth, bleeding, pain, tenesmus and stent-related technical failure. Perforation is particularly important because it can necessitate emergency surgery and may affect subsequent oncological management. The risk profile varies with lesion length and location, complete versus partial obstruction, bowel-wall condition, previous radiotherapy, stent dimensions and operator experience. Uncovered products provide stronger anchoring but may develop tumor ingrowth, while covered products reduce ingrowth and can support removal but generally carry greater migration risk. Stenting may be difficult in very distal rectal lesions, sharply angulated segments or strictures that cannot be traversed safely by a guidewire. Emergency surgery, diverting stoma, surgical resection and conservative management remain alternatives. Regional guidelines, reimbursement policies and hospital capabilities also influence adoption, particularly for bridge-to-surgery use.
Opportunities
The largest opportunities lie in low-profile through-the-scope systems, controlled-release platforms and stents engineered for sigmoid flexures and other tortuous colorectal segments. Products with lower axial force, adequate radial support and minimal foreshortening can improve conformability and deployment predictability. Longer size ranges and precise marker systems can support treatment of irregular or extended lesions. Re-obstruction caused by tumor ingrowth creates opportunities for refined mesh structures and selected stent-in-stent procedures. Covered removable products may address carefully selected benign anastomotic strictures, leaks and fistulas if migration can be controlled and removal protocols are established. Emerging markets offer additional demand as colorectal cancer screening, diagnosis and therapeutic endoscopy expand. Manufacturers can strengthen differentiation by providing physician training, simulation, procedural guidance, rapid technical support and complete accessories. Prospective evidence defining appropriate bridge-to-surgery populations and longer-term oncological outcomes can also expand confidence in standardized use.
Challenges
The central engineering challenge is balancing radial force, axial flexibility, anchoring and atraumatic contact with a thin and sometimes compromised colonic wall. Excessive force may increase pressure injury and perforation, whereas inadequate expansion can result in persistent obstruction or early re-occlusion. High flexibility facilitates navigation but may reduce pushability or deployment control. Stents can foreshorten during expansion, requiring careful lesion measurement and sufficient margins. Severe obstruction may prevent guidewire passage, and the final stent position can be affected by bowel angulation and peristalsis. Clinical comparison is complicated because palliative patients and bridge-to-surgery patients have different endpoints, treatment pathways and follow-up periods. Manufacturers must maintain consistent nitinol properties, mesh geometry, flare dimensions, radiopaque-marker placement, delivery-catheter performance, sterilization and package integrity. Regulatory requirements and purchasing pressure further raise the cost of maintaining a broad size portfolio while meeting quality and clinical-support expectations.
Industry Chain Analysis
The upstream chain includes medical-grade nitinol wire, radiopaque marker materials such as tantalum or platinum alloys, polymer catheters, guidewire-compatible components, delivery handles, lubricious coatings and sterilization services. Manufacturing involves wire preparation and braiding, heat setting, surface treatment, electropolishing, formation of flared or atraumatic ends, marker assembly, optional membrane application, delivery-system loading, packaging and sterilization validation. Midstream value is generated through stent geometry, radial and axial force control, flexibility, foreshortening management, migration resistance, recapture capability and production consistency. Finished systems reach hospitals through manufacturers’ direct sales teams, endoscopy-platform companies and specialized distributors. Downstream users include gastroenterology and endoscopy departments, colorectal surgery units, cancer centers and interventional radiology teams. Value creation extends beyond the implant to clinical evidence, regulatory registration, physician training, procedural support, inventory availability, quality traceability and post-market surveillance. Reliable access to multiple diameters and lengths is important because lesion anatomy varies considerably.
Segment Insights
Uncovered products allow the mesh to contact the bowel wall directly, providing stronger anchoring and reducing migration; they are the established configuration for malignant colorectal obstruction but remain susceptible to tumor ingrowth. Partially covered products seek to combine anchoring at uncovered sections with ingrowth control across the covered body. Fully covered products can reduce tissue ingrowth, support sealing and facilitate removal, but migration is a significant design and clinical limitation. Consequently, covered products occupy more selective applications than uncovered stents.
Further segmentation should include body diameter, expanded length, delivery profile and deployment technology. Commercial body diameters commonly fall into ≤20 mm, 21–24 mm and ≥25 mm groups, while lengths can be classified as ≤60 mm, 61–90 mm and more than 90 mm. Common commercial sizes include 18, 20, 22 and 25 mm diameters and 60–120 mm lengths. Products may also be segmented into conventional release and controlled-release or recapturable systems, as well as through-the-scope and guidewire-guided configurations. These numerical and technical dimensions provide a stronger purchasing-oriented framework than covering structure alone.
Downstream Market Opportunities
Application analysis should separate disease etiology from treatment intent to avoid double counting. By disease, the primary categories are malignant colonic stenosis and obstruction, benign colonic stricture, postoperative anastomotic leakage or fistula, and other conditions. By treatment intent, malignant cases can be divided into palliative treatment and bridge to surgery. “Palliative Treatment” is the correct English term; “Patient Treatment” should not be used. Palliative stenting is intended to relieve obstruction in patients with unresectable disease or those unsuitable for surgery. Bridge-to-surgery placement provides temporary decompression before planned resection in appropriately selected patients. Benign strictures, including selected anastomotic, inflammatory or radiation-related cases, form a smaller and more cautious application field because long-term placement, migration and removal require careful management.
Regional Insights
North America and Europe are mature markets with established colorectal cancer pathways, therapeutic-endoscopy infrastructure and formal clinical guidance. Boston Scientific and Cook Medical have broad hospital access and dedicated colonic stent platforms. European specialists including ENDO-FLEX, Leufen Medical and ELLA-CS participate through gastrointestinal stent portfolios, although product-level availability and indications vary by country. Regional adoption is influenced by colorectal-surgery practice, reimbursement, access to experienced endoscopists and differences in bridge-to-surgery recommendations. Clinical evidence, delivery accuracy and adverse-event reduction carry greater weight than price alone in advanced markets.
South Korea is an important specialist manufacturing base. M.I.Tech, Taewoong Medical and Sewoon Medical provide gastrointestinal stent technologies and multiple enteral configurations. Taewoong Medical is an important omission from the initial list and should be included in the expanded manufacturer pool. Japan has a sophisticated endoscopy market and strong distribution capabilities; Olympus supplies selected colonic stents manufactured by M.I.Tech and should be classified as a product provider or distributor rather than the independent manufacturing source of those devices. China is expanding through Micro-Tech Endoscopy, Jiangsu Vedkang and other domestic gastrointestinal-device manufacturers. T?rkiye and other emerging regions participate through INVAMED and additional suppliers, subject to product registration and current manufacturing verification.
Competitive Landscape Analysis
The competitive landscape combines multinational endoscopy companies with specialized Asian and European stent manufacturers. Boston Scientific competes through the WallFlex colonic platform, multiple diameters and lengths, lower-profile variants and broad international hospital access. Cook Medical offers the Evolution controlled-release uncovered colonic stent, emphasizing deployment control, recapture and navigation through difficult anatomy. M.I.Tech is the manufacturing source of relevant HANAROSTENT colonic products supplied by Olympus in certain markets, so the two companies should not be counted as separate manufacturers for those devices. Taewoong Medical should be added to the core or extended enterprise pool because its Niti-S portfolio includes uncovered, fully covered, end-bare, both-bare and composite colonic stent configurations. Micro-Tech Endoscopy offers colonic and rectal stents with multiple diameters, lengths and covering structures and represents an important Chinese international supplier. ENDO-FLEX, Leufen Medical, ELLA-CS, Sewoon Medical, INVAMED and Jiangsu Vedkang form the broader specialist pool, subject to current product registration and regional availability. Competition centers on force balance, flexibility, migration resistance, delivery profile, release control, clinical evidence, physician access and reliable supply rather than unsupported overall rankings.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Colonic Stent Industry Forecast” looks at past sales and reviews total world Colonic Stent sales in 2025, providing a comprehensive analysis by region and market sector of projected Colonic Stent sales for 2026 through 2032. With Colonic Stent sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Colonic Stent industry.
This Insight Report provides a comprehensive analysis of the global Colonic Stent landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Colonic Stent portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Colonic Stent market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Colonic Stent and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Colonic Stent.
This report presents a comprehensive overview, market shares, and growth opportunities of Colonic Stent market by product type, application, key manufacturers and key regions and countries.
Market Segmentation
Segmentation by Type:
- Fully Covered Colonic Stent
- Partially Covered Colonic Stent
- Non-covered Colonic Stent
Segmentation by Material:
- Nickel-titanium Alloy Stent
- Biodegradable Stent
- Other
Segmentation by Diameter:
- Diameter≤20mm
- Diameter 21–24mm
- Diameter≥25mm
Segmentation by Application:
- Malignant Colonic Stenosis and Obstruction
- Patient Treatment
- Preoperative Bridging Therapy
- Benign Colonic Stenosis
- Other
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Boston Scientific
- Cook Medical
- M.I.Tech
- Olympus Corporation
- ENDO-FLEX GmbH
- Leufen Medical
- Micro-Tech Endoscopy
- ELLA-CS, s.r.o.
- Sewoon Medical
- INVAMED
- Jiangsu Vedkang Medical Science and Technology
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Colonic Stent market?
- What factors are driving Colonic Stent market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Colonic Stent market opportunities vary by end market size?
- How does Colonic Stent break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Colonic Stent Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Colonic Stent by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Colonic Stent by Country/Region, 2021, 2025 & 2032
2.2 Colonic Stent Segment by Type
2.2.1 Fully Covered Colonic Stent
2.2.2 Partially Covered Colonic Stent
2.2.3 Non-covered Colonic Stent
2.2.4 Colonic Stent Sales by Type
2.2.4.1 Global Colonic Stent Sales Market Share by Type (2021-2026)
2.2.4.2 Global Colonic Stent Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Colonic Stent Sale Price by Type (2021-2026)
2.3 Colonic Stent Segment by Material
2.3.1 Nickel-titanium Alloy Stent
2.3.2 Biodegradable Stent
2.3.3 Other
2.3.4 Colonic Stent Sales by Material
2.3.4.1 Global Colonic Stent Sales Market Share by Material (2021-2026)
2.3.4.2 Global Colonic Stent Revenue and Market Share by Material (2021-2026)
2.3.4.3 Global Colonic Stent Sale Price by Material (2021-2026)
2.4 Colonic Stent Segment by Diameter
2.4.1 Diameter≤20mm
2.4.2 Diameter 21–24mm
2.4.3 Diameter≥25mm
2.4.4 Colonic Stent Sales by Diameter
2.4.4.1 Global Colonic Stent Sales Market Share by Diameter (2021-2026)
2.4.4.2 Global Colonic Stent Revenue and Market Share by Diameter (2021-2026)
2.4.4.3 Global Colonic Stent Sale Price by Diameter (2021-2026)
2.5 Colonic Stent Segment by Application
2.5.1 Malignant Colonic Stenosis and Obstruction
2.5.2 Patient Treatment
2.5.3 Preoperative Bridging Therapy
2.5.4 Benign Colonic Stenosis
2.5.5 Other
2.5.6 Colonic Stent Sales by Application
2.5.6.1 Global Colonic Stent Sale Market Share by Application (2021-2026)
2.5.6.2 Global Colonic Stent Revenue and Market Share by Application (2021-2026)
2.5.6.3 Global Colonic Stent Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Colonic Stent Breakdown Data by Company
3.1.1 Global Colonic Stent Annual Sales by Company (2021-2026)
3.1.2 Global Colonic Stent Sales Market Share by Company (2021-2026)
3.2 Global Colonic Stent Annual Revenue by Company (2021-2026)
3.2.1 Global Colonic Stent Revenue by Company (2021-2026)
3.2.2 Global Colonic Stent Revenue Market Share by Company (2021-2026)
3.3 Global Colonic Stent Sale Price by Company
3.4 Key Manufacturers Colonic Stent Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Colonic Stent Product Location Distribution
3.4.2 Players Colonic Stent Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR COLONIC STENT BY GEOGRAPHIC REGION
4.1 World Historic Colonic Stent Market Size by Geographic Region (2021-2026)
4.1.1 Global Colonic Stent Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Colonic Stent Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Colonic Stent Market Size by Country/Region (2021-2026)
4.2.1 Global Colonic Stent Annual Sales by Country/Region (2021-2026)
4.2.2 Global Colonic Stent Annual Revenue by Country/Region (2021-2026)
4.3 Americas Colonic Stent Sales Growth
4.4 APAC Colonic Stent Sales Growth
4.5 Europe Colonic Stent Sales Growth
4.6 Middle East & Africa Colonic Stent Sales Growth
5 AMERICAS
5.1 Americas Colonic Stent Sales by Country
5.1.1 Americas Colonic Stent Sales by Country (2021-2026)
5.1.2 Americas Colonic Stent Revenue by Country (2021-2026)
5.2 Americas Colonic Stent Sales by Type (2021-2026)
5.3 Americas Colonic Stent Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Colonic Stent Sales by Region
6.1.1 APAC Colonic Stent Sales by Region (2021-2026)
6.1.2 APAC Colonic Stent Revenue by Region (2021-2026)
6.2 APAC Colonic Stent Sales by Type (2021-2026)
6.3 APAC Colonic Stent Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Colonic Stent by Country
7.1.1 Europe Colonic Stent Sales by Country (2021-2026)
7.1.2 Europe Colonic Stent Revenue by Country (2021-2026)
7.2 Europe Colonic Stent Sales by Type (2021-2026)
7.3 Europe Colonic Stent Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Colonic Stent by Country
8.1.1 Middle East & Africa Colonic Stent Sales by Country (2021-2026)
8.1.2 Middle East & Africa Colonic Stent Revenue by Country (2021-2026)
8.2 Middle East & Africa Colonic Stent Sales by Type (2021-2026)
8.3 Middle East & Africa Colonic Stent Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Colonic Stent
10.3 Manufacturing Process Analysis of Colonic Stent
10.4 Industry Chain Structure of Colonic Stent
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Colonic Stent Distributors
11.3 Colonic Stent Customer
12 WORLD FORECAST REVIEW FOR COLONIC STENT BY GEOGRAPHIC REGION
12.1 Global Colonic Stent Market Size Forecast by Region
12.1.1 Global Colonic Stent Forecast by Region (2027-2032)
12.1.2 Global Colonic Stent Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Colonic Stent Forecast by Type (2027-2032)
12.7 Global Colonic Stent Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Boston Scientific
13.1.1 Boston Scientific Company Information
13.1.2 Boston Scientific Colonic Stent Product Portfolios and Specifications
13.1.3 Boston Scientific Colonic Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Boston Scientific Main Business Overview
13.1.5 Boston Scientific Latest Developments
13.2 Cook Medical
13.2.1 Cook Medical Company Information
13.2.2 Cook Medical Colonic Stent Product Portfolios and Specifications
13.2.3 Cook Medical Colonic Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Cook Medical Main Business Overview
13.2.5 Cook Medical Latest Developments
13.3 M.I.Tech
13.3.1 M.I.Tech Company Information
13.3.2 M.I.Tech Colonic Stent Product Portfolios and Specifications
13.3.3 M.I.Tech Colonic Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 M.I.Tech Main Business Overview
13.3.5 M.I.Tech Latest Developments
13.4 Olympus Corporation
13.4.1 Olympus Corporation Company Information
13.4.2 Olympus Corporation Colonic Stent Product Portfolios and Specifications
13.4.3 Olympus Corporation Colonic Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Olympus Corporation Main Business Overview
13.4.5 Olympus Corporation Latest Developments
13.5 ENDO-FLEX GmbH
13.5.1 ENDO-FLEX GmbH Company Information
13.5.2 ENDO-FLEX GmbH Colonic Stent Product Portfolios and Specifications
13.5.3 ENDO-FLEX GmbH Colonic Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 ENDO-FLEX GmbH Main Business Overview
13.5.5 ENDO-FLEX GmbH Latest Developments
13.6 Leufen Medical
13.6.1 Leufen Medical Company Information
13.6.2 Leufen Medical Colonic Stent Product Portfolios and Specifications
13.6.3 Leufen Medical Colonic Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Leufen Medical Main Business Overview
13.6.5 Leufen Medical Latest Developments
13.7 Micro-Tech Endoscopy
13.7.1 Micro-Tech Endoscopy Company Information
13.7.2 Micro-Tech Endoscopy Colonic Stent Product Portfolios and Specifications
13.7.3 Micro-Tech Endoscopy Colonic Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Micro-Tech Endoscopy Main Business Overview
13.7.5 Micro-Tech Endoscopy Latest Developments
13.8 ELLA-CS, s.r.o.
13.8.1 ELLA-CS, s.r.o. Company Information
13.8.2 ELLA-CS, s.r.o. Colonic Stent Product Portfolios and Specifications
13.8.3 ELLA-CS, s.r.o. Colonic Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 ELLA-CS, s.r.o. Main Business Overview
13.8.5 ELLA-CS, s.r.o. Latest Developments
13.9 Sewoon Medical
13.9.1 Sewoon Medical Company Information
13.9.2 Sewoon Medical Colonic Stent Product Portfolios and Specifications
13.9.3 Sewoon Medical Colonic Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Sewoon Medical Main Business Overview
13.9.5 Sewoon Medical Latest Developments
13.10 INVAMED
13.10.1 INVAMED Company Information
13.10.2 INVAMED Colonic Stent Product Portfolios and Specifications
13.10.3 INVAMED Colonic Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 INVAMED Main Business Overview
13.10.5 INVAMED Latest Developments
13.11 Jiangsu Vedkang Medical Science and Technology
13.11.1 Jiangsu Vedkang Medical Science and Technology Company Information
13.11.2 Jiangsu Vedkang Medical Science and Technology Colonic Stent Product Portfolios and Specifications
13.11.3 Jiangsu Vedkang Medical Science and Technology Colonic Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Jiangsu Vedkang Medical Science and Technology Main Business Overview
13.11.5 Jiangsu Vedkang Medical Science and Technology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Colonic Stent Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Colonic Stent by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Colonic Stent by Country/Region, 2021, 2025 & 2032
2.2 Colonic Stent Segment by Type
2.2.1 Fully Covered Colonic Stent
2.2.2 Partially Covered Colonic Stent
2.2.3 Non-covered Colonic Stent
2.2.4 Colonic Stent Sales by Type
2.2.4.1 Global Colonic Stent Sales Market Share by Type (2021-2026)
2.2.4.2 Global Colonic Stent Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Colonic Stent Sale Price by Type (2021-2026)
2.3 Colonic Stent Segment by Material
2.3.1 Nickel-titanium Alloy Stent
2.3.2 Biodegradable Stent
2.3.3 Other
2.3.4 Colonic Stent Sales by Material
2.3.4.1 Global Colonic Stent Sales Market Share by Material (2021-2026)
2.3.4.2 Global Colonic Stent Revenue and Market Share by Material (2021-2026)
2.3.4.3 Global Colonic Stent Sale Price by Material (2021-2026)
2.4 Colonic Stent Segment by Diameter
2.4.1 Diameter≤20mm
2.4.2 Diameter 21–24mm
2.4.3 Diameter≥25mm
2.4.4 Colonic Stent Sales by Diameter
2.4.4.1 Global Colonic Stent Sales Market Share by Diameter (2021-2026)
2.4.4.2 Global Colonic Stent Revenue and Market Share by Diameter (2021-2026)
2.4.4.3 Global Colonic Stent Sale Price by Diameter (2021-2026)
2.5 Colonic Stent Segment by Application
2.5.1 Malignant Colonic Stenosis and Obstruction
2.5.2 Patient Treatment
2.5.3 Preoperative Bridging Therapy
2.5.4 Benign Colonic Stenosis
2.5.5 Other
2.5.6 Colonic Stent Sales by Application
2.5.6.1 Global Colonic Stent Sale Market Share by Application (2021-2026)
2.5.6.2 Global Colonic Stent Revenue and Market Share by Application (2021-2026)
2.5.6.3 Global Colonic Stent Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Colonic Stent Breakdown Data by Company
3.1.1 Global Colonic Stent Annual Sales by Company (2021-2026)
3.1.2 Global Colonic Stent Sales Market Share by Company (2021-2026)
3.2 Global Colonic Stent Annual Revenue by Company (2021-2026)
3.2.1 Global Colonic Stent Revenue by Company (2021-2026)
3.2.2 Global Colonic Stent Revenue Market Share by Company (2021-2026)
3.3 Global Colonic Stent Sale Price by Company
3.4 Key Manufacturers Colonic Stent Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Colonic Stent Product Location Distribution
3.4.2 Players Colonic Stent Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR COLONIC STENT BY GEOGRAPHIC REGION
4.1 World Historic Colonic Stent Market Size by Geographic Region (2021-2026)
4.1.1 Global Colonic Stent Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Colonic Stent Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Colonic Stent Market Size by Country/Region (2021-2026)
4.2.1 Global Colonic Stent Annual Sales by Country/Region (2021-2026)
4.2.2 Global Colonic Stent Annual Revenue by Country/Region (2021-2026)
4.3 Americas Colonic Stent Sales Growth
4.4 APAC Colonic Stent Sales Growth
4.5 Europe Colonic Stent Sales Growth
4.6 Middle East & Africa Colonic Stent Sales Growth
5 AMERICAS
5.1 Americas Colonic Stent Sales by Country
5.1.1 Americas Colonic Stent Sales by Country (2021-2026)
5.1.2 Americas Colonic Stent Revenue by Country (2021-2026)
5.2 Americas Colonic Stent Sales by Type (2021-2026)
5.3 Americas Colonic Stent Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Colonic Stent Sales by Region
6.1.1 APAC Colonic Stent Sales by Region (2021-2026)
6.1.2 APAC Colonic Stent Revenue by Region (2021-2026)
6.2 APAC Colonic Stent Sales by Type (2021-2026)
6.3 APAC Colonic Stent Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Colonic Stent by Country
7.1.1 Europe Colonic Stent Sales by Country (2021-2026)
7.1.2 Europe Colonic Stent Revenue by Country (2021-2026)
7.2 Europe Colonic Stent Sales by Type (2021-2026)
7.3 Europe Colonic Stent Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Colonic Stent by Country
8.1.1 Middle East & Africa Colonic Stent Sales by Country (2021-2026)
8.1.2 Middle East & Africa Colonic Stent Revenue by Country (2021-2026)
8.2 Middle East & Africa Colonic Stent Sales by Type (2021-2026)
8.3 Middle East & Africa Colonic Stent Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Colonic Stent
10.3 Manufacturing Process Analysis of Colonic Stent
10.4 Industry Chain Structure of Colonic Stent
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Colonic Stent Distributors
11.3 Colonic Stent Customer
12 WORLD FORECAST REVIEW FOR COLONIC STENT BY GEOGRAPHIC REGION
12.1 Global Colonic Stent Market Size Forecast by Region
12.1.1 Global Colonic Stent Forecast by Region (2027-2032)
12.1.2 Global Colonic Stent Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Colonic Stent Forecast by Type (2027-2032)
12.7 Global Colonic Stent Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Boston Scientific
13.1.1 Boston Scientific Company Information
13.1.2 Boston Scientific Colonic Stent Product Portfolios and Specifications
13.1.3 Boston Scientific Colonic Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Boston Scientific Main Business Overview
13.1.5 Boston Scientific Latest Developments
13.2 Cook Medical
13.2.1 Cook Medical Company Information
13.2.2 Cook Medical Colonic Stent Product Portfolios and Specifications
13.2.3 Cook Medical Colonic Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Cook Medical Main Business Overview
13.2.5 Cook Medical Latest Developments
13.3 M.I.Tech
13.3.1 M.I.Tech Company Information
13.3.2 M.I.Tech Colonic Stent Product Portfolios and Specifications
13.3.3 M.I.Tech Colonic Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 M.I.Tech Main Business Overview
13.3.5 M.I.Tech Latest Developments
13.4 Olympus Corporation
13.4.1 Olympus Corporation Company Information
13.4.2 Olympus Corporation Colonic Stent Product Portfolios and Specifications
13.4.3 Olympus Corporation Colonic Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Olympus Corporation Main Business Overview
13.4.5 Olympus Corporation Latest Developments
13.5 ENDO-FLEX GmbH
13.5.1 ENDO-FLEX GmbH Company Information
13.5.2 ENDO-FLEX GmbH Colonic Stent Product Portfolios and Specifications
13.5.3 ENDO-FLEX GmbH Colonic Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 ENDO-FLEX GmbH Main Business Overview
13.5.5 ENDO-FLEX GmbH Latest Developments
13.6 Leufen Medical
13.6.1 Leufen Medical Company Information
13.6.2 Leufen Medical Colonic Stent Product Portfolios and Specifications
13.6.3 Leufen Medical Colonic Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Leufen Medical Main Business Overview
13.6.5 Leufen Medical Latest Developments
13.7 Micro-Tech Endoscopy
13.7.1 Micro-Tech Endoscopy Company Information
13.7.2 Micro-Tech Endoscopy Colonic Stent Product Portfolios and Specifications
13.7.3 Micro-Tech Endoscopy Colonic Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Micro-Tech Endoscopy Main Business Overview
13.7.5 Micro-Tech Endoscopy Latest Developments
13.8 ELLA-CS, s.r.o.
13.8.1 ELLA-CS, s.r.o. Company Information
13.8.2 ELLA-CS, s.r.o. Colonic Stent Product Portfolios and Specifications
13.8.3 ELLA-CS, s.r.o. Colonic Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 ELLA-CS, s.r.o. Main Business Overview
13.8.5 ELLA-CS, s.r.o. Latest Developments
13.9 Sewoon Medical
13.9.1 Sewoon Medical Company Information
13.9.2 Sewoon Medical Colonic Stent Product Portfolios and Specifications
13.9.3 Sewoon Medical Colonic Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Sewoon Medical Main Business Overview
13.9.5 Sewoon Medical Latest Developments
13.10 INVAMED
13.10.1 INVAMED Company Information
13.10.2 INVAMED Colonic Stent Product Portfolios and Specifications
13.10.3 INVAMED Colonic Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 INVAMED Main Business Overview
13.10.5 INVAMED Latest Developments
13.11 Jiangsu Vedkang Medical Science and Technology
13.11.1 Jiangsu Vedkang Medical Science and Technology Company Information
13.11.2 Jiangsu Vedkang Medical Science and Technology Colonic Stent Product Portfolios and Specifications
13.11.3 Jiangsu Vedkang Medical Science and Technology Colonic Stent Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Jiangsu Vedkang Medical Science and Technology Main Business Overview
13.11.5 Jiangsu Vedkang Medical Science and Technology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Colonic Stent Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Colonic Stent Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Fully Covered Colonic Stent
Table 4. Major Players of Partially Covered Colonic Stent
Table 5. Major Players of Non-covered Colonic Stent
Table 6. Global Colonic Stent Sales by Type (2021-2026) & (K Units)
Table 7. Global Colonic Stent Sales Market Share by Type (2021-2026)
Table 8. Global Colonic Stent Revenue by Type (2021-2026) & ($ million)
Table 9. Global Colonic Stent Revenue Market Share by Type (2021-2026)
Table 10. Global Colonic Stent Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Major Players of Nickel-titanium Alloy Stent
Table 12. Major Players of Biodegradable Stent
Table 13. Major Players of Other
Table 14. Global Colonic Stent Sales by Material (2021-2026) & (K Units)
Table 15. Global Colonic Stent Sales Market Share by Material (2021-2026)
Table 16. Global Colonic Stent Revenue by Material (2021-2026) & ($ million)
Table 17. Global Colonic Stent Revenue Market Share by Material (2021-2026)
Table 18. Global Colonic Stent Sale Price by Material (2021-2026) & (US$/Unit)
Table 19. Major Players of Diameter≤20mm
Table 20. Major Players of Diameter 21–24mm
Table 21. Major Players of Diameter≥25mm
Table 22. Global Colonic Stent Sales by Diameter (2021-2026) & (K Units)
Table 23. Global Colonic Stent Sales Market Share by Diameter (2021-2026)
Table 24. Global Colonic Stent Revenue by Diameter (2021-2026) & ($ million)
Table 25. Global Colonic Stent Revenue Market Share by Diameter (2021-2026)
Table 26. Global Colonic Stent Sale Price by Diameter (2021-2026) & (US$/Unit)
Table 27. Global Colonic Stent Sale by Application (2021-2026) & (K Units)
Table 28. Global Colonic Stent Sale Market Share by Application (2021-2026)
Table 29. Global Colonic Stent Revenue by Application (2021-2026) & ($ million)
Table 30. Global Colonic Stent Revenue Market Share by Application (2021-2026)
Table 31. Global Colonic Stent Sale Price by Application (2021-2026) & (US$/Unit)
Table 32. Global Colonic Stent Sales by Company (2021-2026) & (K Units)
Table 33. Global Colonic Stent Sales Market Share by Company (2021-2026)
Table 34. Global Colonic Stent Revenue by Company (2021-2026) & ($ millions)
Table 35. Global Colonic Stent Revenue Market Share by Company (2021-2026)
Table 36. Global Colonic Stent Sale Price by Company (2021-2026) & (US$/Unit)
Table 37. Key Manufacturers Colonic Stent Producing Area Distribution and Sales Area
Table 38. Players Colonic Stent Products Offered
Table 39. Colonic Stent Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 40. New Products and Potential Entrants
Table 41. Market M&A Activity & Strategy
Table 42. Global Colonic Stent Sales by Geographic Region (2021-2026) & (K Units)
Table 43. Global Colonic Stent Sales Market Share Geographic Region (2021-2026)
Table 44. Global Colonic Stent Revenue by Geographic Region (2021-2026) & ($ millions)
Table 45. Global Colonic Stent Revenue Market Share by Geographic Region (2021-2026)
Table 46. Global Colonic Stent Sales by Country/Region (2021-2026) & (K Units)
Table 47. Global Colonic Stent Sales Market Share by Country/Region (2021-2026)
Table 48. Global Colonic Stent Revenue by Country/Region (2021-2026) & ($ millions)
Table 49. Global Colonic Stent Revenue Market Share by Country/Region (2021-2026)
Table 50. Americas Colonic Stent Sales by Country (2021-2026) & (K Units)
Table 51. Americas Colonic Stent Sales Market Share by Country (2021-2026)
Table 52. Americas Colonic Stent Revenue by Country (2021-2026) & ($ millions)
Table 53. Americas Colonic Stent Sales by Type (2021-2026) & (K Units)
Table 54. Americas Colonic Stent Sales by Application (2021-2026) & (K Units)
Table 55. APAC Colonic Stent Sales by Region (2021-2026) & (K Units)
Table 56. APAC Colonic Stent Sales Market Share by Region (2021-2026)
Table 57. APAC Colonic Stent Revenue by Region (2021-2026) & ($ millions)
Table 58. APAC Colonic Stent Sales by Type (2021-2026) & (K Units)
Table 59. APAC Colonic Stent Sales by Application (2021-2026) & (K Units)
Table 60. Europe Colonic Stent Sales by Country (2021-2026) & (K Units)
Table 61. Europe Colonic Stent Revenue by Country (2021-2026) & ($ millions)
Table 62. Europe Colonic Stent Sales by Type (2021-2026) & (K Units)
Table 63. Europe Colonic Stent Sales by Application (2021-2026) & (K Units)
Table 64. Middle East & Africa Colonic Stent Sales by Country (2021-2026) & (K Units)
Table 65. Middle East & Africa Colonic Stent Revenue Market Share by Country (2021-2026)
Table 66. Middle East & Africa Colonic Stent Sales by Type (2021-2026) & (K Units)
Table 67. Middle East & Africa Colonic Stent Sales by Application (2021-2026) & (K Units)
Table 68. Key Market Drivers & Growth Opportunities of Colonic Stent
Table 69. Key Market Challenges & Risks of Colonic Stent
Table 70. Key Industry Trends of Colonic Stent
Table 71. Colonic Stent Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Colonic Stent Distributors List
Table 74. Colonic Stent Customer List
Table 75. Global Colonic Stent Sales Forecast by Region (2027-2032) & (K Units)
Table 76. Global Colonic Stent Revenue Forecast by Region (2027-2032) & ($ millions)
Table 77. Americas Colonic Stent Sales Forecast by Country (2027-2032) & (K Units)
Table 78. Americas Colonic Stent Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 79. APAC Colonic Stent Sales Forecast by Region (2027-2032) & (K Units)
Table 80. APAC Colonic Stent Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 81. Europe Colonic Stent Sales Forecast by Country (2027-2032) & (K Units)
Table 82. Europe Colonic Stent Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Middle East & Africa Colonic Stent Sales Forecast by Country (2027-2032) & (K Units)
Table 84. Middle East & Africa Colonic Stent Revenue Forecast by Country (2027-2032) & ($ millions)
Table 85. Global Colonic Stent Sales Forecast by Type (2027-2032) & (K Units)
Table 86. Global Colonic Stent Revenue Forecast by Type (2027-2032) & ($ millions)
Table 87. Global Colonic Stent Sales Forecast by Application (2027-2032) & (K Units)
Table 88. Global Colonic Stent Revenue Forecast by Application (2027-2032) & ($ millions)
Table 89. Boston Scientific Basic Information, Colonic Stent Manufacturing Base, Sales Area and Its Competitors
Table 90. Boston Scientific Colonic Stent Product Portfolios and Specifications
Table 91. Boston Scientific Colonic Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Boston Scientific Main Business
Table 93. Boston Scientific Latest Developments
Table 94. Cook Medical Basic Information, Colonic Stent Manufacturing Base, Sales Area and Its Competitors
Table 95. Cook Medical Colonic Stent Product Portfolios and Specifications
Table 96. Cook Medical Colonic Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Cook Medical Main Business
Table 98. Cook Medical Latest Developments
Table 99. M.I.Tech Basic Information, Colonic Stent Manufacturing Base, Sales Area and Its Competitors
Table 100. M.I.Tech Colonic Stent Product Portfolios and Specifications
Table 101. M.I.Tech Colonic Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. M.I.Tech Main Business
Table 103. M.I.Tech Latest Developments
Table 104. Olympus Corporation Basic Information, Colonic Stent Manufacturing Base, Sales Area and Its Competitors
Table 105. Olympus Corporation Colonic Stent Product Portfolios and Specifications
Table 106. Olympus Corporation Colonic Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Olympus Corporation Main Business
Table 108. Olympus Corporation Latest Developments
Table 109. ENDO-FLEX GmbH Basic Information, Colonic Stent Manufacturing Base, Sales Area and Its Competitors
Table 110. ENDO-FLEX GmbH Colonic Stent Product Portfolios and Specifications
Table 111. ENDO-FLEX GmbH Colonic Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. ENDO-FLEX GmbH Main Business
Table 113. ENDO-FLEX GmbH Latest Developments
Table 114. Leufen Medical Basic Information, Colonic Stent Manufacturing Base, Sales Area and Its Competitors
Table 115. Leufen Medical Colonic Stent Product Portfolios and Specifications
Table 116. Leufen Medical Colonic Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Leufen Medical Main Business
Table 118. Leufen Medical Latest Developments
Table 119. Micro-Tech Endoscopy Basic Information, Colonic Stent Manufacturing Base, Sales Area and Its Competitors
Table 120. Micro-Tech Endoscopy Colonic Stent Product Portfolios and Specifications
Table 121. Micro-Tech Endoscopy Colonic Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Micro-Tech Endoscopy Main Business
Table 123. Micro-Tech Endoscopy Latest Developments
Table 124. ELLA-CS, s.r.o. Basic Information, Colonic Stent Manufacturing Base, Sales Area and Its Competitors
Table 125. ELLA-CS, s.r.o. Colonic Stent Product Portfolios and Specifications
Table 126. ELLA-CS, s.r.o. Colonic Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. ELLA-CS, s.r.o. Main Business
Table 128. ELLA-CS, s.r.o. Latest Developments
Table 129. Sewoon Medical Basic Information, Colonic Stent Manufacturing Base, Sales Area and Its Competitors
Table 130. Sewoon Medical Colonic Stent Product Portfolios and Specifications
Table 131. Sewoon Medical Colonic Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Sewoon Medical Main Business
Table 133. Sewoon Medical Latest Developments
Table 134. INVAMED Basic Information, Colonic Stent Manufacturing Base, Sales Area and Its Competitors
Table 135. INVAMED Colonic Stent Product Portfolios and Specifications
Table 136. INVAMED Colonic Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. INVAMED Main Business
Table 138. INVAMED Latest Developments
Table 139. Jiangsu Vedkang Medical Science and Technology Basic Information, Colonic Stent Manufacturing Base, Sales Area and Its Competitors
Table 140. Jiangsu Vedkang Medical Science and Technology Colonic Stent Product Portfolios and Specifications
Table 141. Jiangsu Vedkang Medical Science and Technology Colonic Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. Jiangsu Vedkang Medical Science and Technology Main Business
Table 143. Jiangsu Vedkang Medical Science and Technology Latest Developments
Table 1. Colonic Stent Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Colonic Stent Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Fully Covered Colonic Stent
Table 4. Major Players of Partially Covered Colonic Stent
Table 5. Major Players of Non-covered Colonic Stent
Table 6. Global Colonic Stent Sales by Type (2021-2026) & (K Units)
Table 7. Global Colonic Stent Sales Market Share by Type (2021-2026)
Table 8. Global Colonic Stent Revenue by Type (2021-2026) & ($ million)
Table 9. Global Colonic Stent Revenue Market Share by Type (2021-2026)
Table 10. Global Colonic Stent Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Major Players of Nickel-titanium Alloy Stent
Table 12. Major Players of Biodegradable Stent
Table 13. Major Players of Other
Table 14. Global Colonic Stent Sales by Material (2021-2026) & (K Units)
Table 15. Global Colonic Stent Sales Market Share by Material (2021-2026)
Table 16. Global Colonic Stent Revenue by Material (2021-2026) & ($ million)
Table 17. Global Colonic Stent Revenue Market Share by Material (2021-2026)
Table 18. Global Colonic Stent Sale Price by Material (2021-2026) & (US$/Unit)
Table 19. Major Players of Diameter≤20mm
Table 20. Major Players of Diameter 21–24mm
Table 21. Major Players of Diameter≥25mm
Table 22. Global Colonic Stent Sales by Diameter (2021-2026) & (K Units)
Table 23. Global Colonic Stent Sales Market Share by Diameter (2021-2026)
Table 24. Global Colonic Stent Revenue by Diameter (2021-2026) & ($ million)
Table 25. Global Colonic Stent Revenue Market Share by Diameter (2021-2026)
Table 26. Global Colonic Stent Sale Price by Diameter (2021-2026) & (US$/Unit)
Table 27. Global Colonic Stent Sale by Application (2021-2026) & (K Units)
Table 28. Global Colonic Stent Sale Market Share by Application (2021-2026)
Table 29. Global Colonic Stent Revenue by Application (2021-2026) & ($ million)
Table 30. Global Colonic Stent Revenue Market Share by Application (2021-2026)
Table 31. Global Colonic Stent Sale Price by Application (2021-2026) & (US$/Unit)
Table 32. Global Colonic Stent Sales by Company (2021-2026) & (K Units)
Table 33. Global Colonic Stent Sales Market Share by Company (2021-2026)
Table 34. Global Colonic Stent Revenue by Company (2021-2026) & ($ millions)
Table 35. Global Colonic Stent Revenue Market Share by Company (2021-2026)
Table 36. Global Colonic Stent Sale Price by Company (2021-2026) & (US$/Unit)
Table 37. Key Manufacturers Colonic Stent Producing Area Distribution and Sales Area
Table 38. Players Colonic Stent Products Offered
Table 39. Colonic Stent Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 40. New Products and Potential Entrants
Table 41. Market M&A Activity & Strategy
Table 42. Global Colonic Stent Sales by Geographic Region (2021-2026) & (K Units)
Table 43. Global Colonic Stent Sales Market Share Geographic Region (2021-2026)
Table 44. Global Colonic Stent Revenue by Geographic Region (2021-2026) & ($ millions)
Table 45. Global Colonic Stent Revenue Market Share by Geographic Region (2021-2026)
Table 46. Global Colonic Stent Sales by Country/Region (2021-2026) & (K Units)
Table 47. Global Colonic Stent Sales Market Share by Country/Region (2021-2026)
Table 48. Global Colonic Stent Revenue by Country/Region (2021-2026) & ($ millions)
Table 49. Global Colonic Stent Revenue Market Share by Country/Region (2021-2026)
Table 50. Americas Colonic Stent Sales by Country (2021-2026) & (K Units)
Table 51. Americas Colonic Stent Sales Market Share by Country (2021-2026)
Table 52. Americas Colonic Stent Revenue by Country (2021-2026) & ($ millions)
Table 53. Americas Colonic Stent Sales by Type (2021-2026) & (K Units)
Table 54. Americas Colonic Stent Sales by Application (2021-2026) & (K Units)
Table 55. APAC Colonic Stent Sales by Region (2021-2026) & (K Units)
Table 56. APAC Colonic Stent Sales Market Share by Region (2021-2026)
Table 57. APAC Colonic Stent Revenue by Region (2021-2026) & ($ millions)
Table 58. APAC Colonic Stent Sales by Type (2021-2026) & (K Units)
Table 59. APAC Colonic Stent Sales by Application (2021-2026) & (K Units)
Table 60. Europe Colonic Stent Sales by Country (2021-2026) & (K Units)
Table 61. Europe Colonic Stent Revenue by Country (2021-2026) & ($ millions)
Table 62. Europe Colonic Stent Sales by Type (2021-2026) & (K Units)
Table 63. Europe Colonic Stent Sales by Application (2021-2026) & (K Units)
Table 64. Middle East & Africa Colonic Stent Sales by Country (2021-2026) & (K Units)
Table 65. Middle East & Africa Colonic Stent Revenue Market Share by Country (2021-2026)
Table 66. Middle East & Africa Colonic Stent Sales by Type (2021-2026) & (K Units)
Table 67. Middle East & Africa Colonic Stent Sales by Application (2021-2026) & (K Units)
Table 68. Key Market Drivers & Growth Opportunities of Colonic Stent
Table 69. Key Market Challenges & Risks of Colonic Stent
Table 70. Key Industry Trends of Colonic Stent
Table 71. Colonic Stent Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Colonic Stent Distributors List
Table 74. Colonic Stent Customer List
Table 75. Global Colonic Stent Sales Forecast by Region (2027-2032) & (K Units)
Table 76. Global Colonic Stent Revenue Forecast by Region (2027-2032) & ($ millions)
Table 77. Americas Colonic Stent Sales Forecast by Country (2027-2032) & (K Units)
Table 78. Americas Colonic Stent Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 79. APAC Colonic Stent Sales Forecast by Region (2027-2032) & (K Units)
Table 80. APAC Colonic Stent Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 81. Europe Colonic Stent Sales Forecast by Country (2027-2032) & (K Units)
Table 82. Europe Colonic Stent Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Middle East & Africa Colonic Stent Sales Forecast by Country (2027-2032) & (K Units)
Table 84. Middle East & Africa Colonic Stent Revenue Forecast by Country (2027-2032) & ($ millions)
Table 85. Global Colonic Stent Sales Forecast by Type (2027-2032) & (K Units)
Table 86. Global Colonic Stent Revenue Forecast by Type (2027-2032) & ($ millions)
Table 87. Global Colonic Stent Sales Forecast by Application (2027-2032) & (K Units)
Table 88. Global Colonic Stent Revenue Forecast by Application (2027-2032) & ($ millions)
Table 89. Boston Scientific Basic Information, Colonic Stent Manufacturing Base, Sales Area and Its Competitors
Table 90. Boston Scientific Colonic Stent Product Portfolios and Specifications
Table 91. Boston Scientific Colonic Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Boston Scientific Main Business
Table 93. Boston Scientific Latest Developments
Table 94. Cook Medical Basic Information, Colonic Stent Manufacturing Base, Sales Area and Its Competitors
Table 95. Cook Medical Colonic Stent Product Portfolios and Specifications
Table 96. Cook Medical Colonic Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Cook Medical Main Business
Table 98. Cook Medical Latest Developments
Table 99. M.I.Tech Basic Information, Colonic Stent Manufacturing Base, Sales Area and Its Competitors
Table 100. M.I.Tech Colonic Stent Product Portfolios and Specifications
Table 101. M.I.Tech Colonic Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. M.I.Tech Main Business
Table 103. M.I.Tech Latest Developments
Table 104. Olympus Corporation Basic Information, Colonic Stent Manufacturing Base, Sales Area and Its Competitors
Table 105. Olympus Corporation Colonic Stent Product Portfolios and Specifications
Table 106. Olympus Corporation Colonic Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Olympus Corporation Main Business
Table 108. Olympus Corporation Latest Developments
Table 109. ENDO-FLEX GmbH Basic Information, Colonic Stent Manufacturing Base, Sales Area and Its Competitors
Table 110. ENDO-FLEX GmbH Colonic Stent Product Portfolios and Specifications
Table 111. ENDO-FLEX GmbH Colonic Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. ENDO-FLEX GmbH Main Business
Table 113. ENDO-FLEX GmbH Latest Developments
Table 114. Leufen Medical Basic Information, Colonic Stent Manufacturing Base, Sales Area and Its Competitors
Table 115. Leufen Medical Colonic Stent Product Portfolios and Specifications
Table 116. Leufen Medical Colonic Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Leufen Medical Main Business
Table 118. Leufen Medical Latest Developments
Table 119. Micro-Tech Endoscopy Basic Information, Colonic Stent Manufacturing Base, Sales Area and Its Competitors
Table 120. Micro-Tech Endoscopy Colonic Stent Product Portfolios and Specifications
Table 121. Micro-Tech Endoscopy Colonic Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Micro-Tech Endoscopy Main Business
Table 123. Micro-Tech Endoscopy Latest Developments
Table 124. ELLA-CS, s.r.o. Basic Information, Colonic Stent Manufacturing Base, Sales Area and Its Competitors
Table 125. ELLA-CS, s.r.o. Colonic Stent Product Portfolios and Specifications
Table 126. ELLA-CS, s.r.o. Colonic Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. ELLA-CS, s.r.o. Main Business
Table 128. ELLA-CS, s.r.o. Latest Developments
Table 129. Sewoon Medical Basic Information, Colonic Stent Manufacturing Base, Sales Area and Its Competitors
Table 130. Sewoon Medical Colonic Stent Product Portfolios and Specifications
Table 131. Sewoon Medical Colonic Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Sewoon Medical Main Business
Table 133. Sewoon Medical Latest Developments
Table 134. INVAMED Basic Information, Colonic Stent Manufacturing Base, Sales Area and Its Competitors
Table 135. INVAMED Colonic Stent Product Portfolios and Specifications
Table 136. INVAMED Colonic Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. INVAMED Main Business
Table 138. INVAMED Latest Developments
Table 139. Jiangsu Vedkang Medical Science and Technology Basic Information, Colonic Stent Manufacturing Base, Sales Area and Its Competitors
Table 140. Jiangsu Vedkang Medical Science and Technology Colonic Stent Product Portfolios and Specifications
Table 141. Jiangsu Vedkang Medical Science and Technology Colonic Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. Jiangsu Vedkang Medical Science and Technology Main Business
Table 143. Jiangsu Vedkang Medical Science and Technology Latest Developments
LIST OF FIGURES
Figure 1. Picture of Colonic Stent
Figure 2. Colonic Stent Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Colonic Stent Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Colonic Stent Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Colonic Stent Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Colonic Stent Sales Market Share by Country/Region (2025)
Figure 10. Colonic Stent Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Fully Covered Colonic Stent
Figure 12. Product Picture of Partially Covered Colonic Stent
Figure 13. Product Picture of Non-covered Colonic Stent
Figure 14. Global Colonic Stent Sales Market Share by Type in 2026
Figure 15. Global Colonic Stent Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Nickel-titanium Alloy Stent
Figure 17. Product Picture of Biodegradable Stent
Figure 18. Product Picture of Other
Figure 19. Global Colonic Stent Sales Market Share by Material in 2026
Figure 20. Global Colonic Stent Revenue Market Share by Material (2021-2026)
Figure 21. Product Picture of Diameter≤20mm
Figure 22. Product Picture of Diameter 21–24mm
Figure 23. Product Picture of Diameter≥25mm
Figure 24. Global Colonic Stent Sales Market Share by Diameter in 2026
Figure 25. Global Colonic Stent Revenue Market Share by Diameter (2021-2026)
Figure 26. Colonic Stent Consumed in Malignant Colonic Stenosis and Obstruction
Figure 27. Global Colonic Stent Market: Malignant Colonic Stenosis and Obstruction (2021-2026) & (K Units)
Figure 28. Colonic Stent Consumed in Patient Treatment
Figure 29. Global Colonic Stent Market: Patient Treatment (2021-2026) & (K Units)
Figure 30. Colonic Stent Consumed in Preoperative Bridging Therapy
Figure 31. Global Colonic Stent Market: Preoperative Bridging Therapy (2021-2026) & (K Units)
Figure 32. Colonic Stent Consumed in Benign Colonic Stenosis
Figure 33. Global Colonic Stent Market: Benign Colonic Stenosis (2021-2026) & (K Units)
Figure 34. Colonic Stent Consumed in Other
Figure 35. Global Colonic Stent Market: Other (2021-2026) & (K Units)
Figure 36. Global Colonic Stent Sale Market Share by Application (2025)
Figure 37. Global Colonic Stent Revenue Market Share by Application in 2025
Figure 38. Colonic Stent Sales by Company in 2025 (K Units)
Figure 39. Global Colonic Stent Sales Market Share by Company in 2025
Figure 40. Colonic Stent Revenue by Company in 2025 ($ millions)
Figure 41. Global Colonic Stent Revenue Market Share by Company in 2025
Figure 42. Global Colonic Stent Sales Market Share by Geographic Region (2021-2026)
Figure 43. Global Colonic Stent Revenue Market Share by Geographic Region in 2025
Figure 44. Americas Colonic Stent Sales 2021-2026 (K Units)
Figure 45. Americas Colonic Stent Revenue 2021-2026 ($ millions)
Figure 46. APAC Colonic Stent Sales 2021-2026 (K Units)
Figure 47. APAC Colonic Stent Revenue 2021-2026 ($ millions)
Figure 48. Europe Colonic Stent Sales 2021-2026 (K Units)
Figure 49. Europe Colonic Stent Revenue 2021-2026 ($ millions)
Figure 50. Middle East & Africa Colonic Stent Sales 2021-2026 (K Units)
Figure 51. Middle East & Africa Colonic Stent Revenue 2021-2026 ($ millions)
Figure 52. Americas Colonic Stent Sales Market Share by Country in 2025
Figure 53. Americas Colonic Stent Revenue Market Share by Country (2021-2026)
Figure 54. Americas Colonic Stent Sales Market Share by Type (2021-2026)
Figure 55. Americas Colonic Stent Sales Market Share by Application (2021-2026)
Figure 56. United States Colonic Stent Revenue Growth 2021-2026 ($ millions)
Figure 57. Canada Colonic Stent Revenue Growth 2021-2026 ($ millions)
Figure 58. Mexico Colonic Stent Revenue Growth 2021-2026 ($ millions)
Figure 59. Brazil Colonic Stent Revenue Growth 2021-2026 ($ millions)
Figure 60. APAC Colonic Stent Sales Market Share by Region in 2025
Figure 61. APAC Colonic Stent Revenue Market Share by Region (2021-2026)
Figure 62. APAC Colonic Stent Sales Market Share by Type (2021-2026)
Figure 63. APAC Colonic Stent Sales Market Share by Application (2021-2026)
Figure 64. China Colonic Stent Revenue Growth 2021-2026 ($ millions)
Figure 65. Japan Colonic Stent Revenue Growth 2021-2026 ($ millions)
Figure 66. South Korea Colonic Stent Revenue Growth 2021-2026 ($ millions)
Figure 67. Southeast Asia Colonic Stent Revenue Growth 2021-2026 ($ millions)
Figure 68. India Colonic Stent Revenue Growth 2021-2026 ($ millions)
Figure 69. Australia Colonic Stent Revenue Growth 2021-2026 ($ millions)
Figure 70. China Taiwan Colonic Stent Revenue Growth 2021-2026 ($ millions)
Figure 71. Europe Colonic Stent Sales Market Share by Country in 2025
Figure 72. Europe Colonic Stent Revenue Market Share by Country (2021-2026)
Figure 73. Europe Colonic Stent Sales Market Share by Type (2021-2026)
Figure 74. Europe Colonic Stent Sales Market Share by Application (2021-2026)
Figure 75. Germany Colonic Stent Revenue Growth 2021-2026 ($ millions)
Figure 76. France Colonic Stent Revenue Growth 2021-2026 ($ millions)
Figure 77. UK Colonic Stent Revenue Growth 2021-2026 ($ millions)
Figure 78. Italy Colonic Stent Revenue Growth 2021-2026 ($ millions)
Figure 79. Russia Colonic Stent Revenue Growth 2021-2026 ($ millions)
Figure 80. Middle East & Africa Colonic Stent Sales Market Share by Country (2021-2026)
Figure 81. Middle East & Africa Colonic Stent Sales Market Share by Type (2021-2026)
Figure 82. Middle East & Africa Colonic Stent Sales Market Share by Application (2021-2026)
Figure 83. Egypt Colonic Stent Revenue Growth 2021-2026 ($ millions)
Figure 84. South Africa Colonic Stent Revenue Growth 2021-2026 ($ millions)
Figure 85. Israel Colonic Stent Revenue Growth 2021-2026 ($ millions)
Figure 86. Turkey Colonic Stent Revenue Growth 2021-2026 ($ millions)
Figure 87. GCC Countries Colonic Stent Revenue Growth 2021-2026 ($ millions)
Figure 88. Manufacturing Cost Structure Analysis of Colonic Stent in 2026
Figure 89. Manufacturing Process Analysis of Colonic Stent
Figure 90. Industry Chain Structure of Colonic Stent
Figure 91. Channels of Distribution
Figure 92. Global Colonic Stent Sales Market Forecast by Region (2027-2032)
Figure 93. Global Colonic Stent Revenue Market Share Forecast by Region (2027-2032)
Figure 94. Global Colonic Stent Sales Market Share Forecast by Type (2027-2032)
Figure 95. Global Colonic Stent Revenue Market Share Forecast by Type (2027-2032)
Figure 96. Global Colonic Stent Sales Market Share Forecast by Application (2027-2032)
Figure 97. Global Colonic Stent Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Colonic Stent
Figure 2. Colonic Stent Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Colonic Stent Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Colonic Stent Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Colonic Stent Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Colonic Stent Sales Market Share by Country/Region (2025)
Figure 10. Colonic Stent Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Fully Covered Colonic Stent
Figure 12. Product Picture of Partially Covered Colonic Stent
Figure 13. Product Picture of Non-covered Colonic Stent
Figure 14. Global Colonic Stent Sales Market Share by Type in 2026
Figure 15. Global Colonic Stent Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Nickel-titanium Alloy Stent
Figure 17. Product Picture of Biodegradable Stent
Figure 18. Product Picture of Other
Figure 19. Global Colonic Stent Sales Market Share by Material in 2026
Figure 20. Global Colonic Stent Revenue Market Share by Material (2021-2026)
Figure 21. Product Picture of Diameter≤20mm
Figure 22. Product Picture of Diameter 21–24mm
Figure 23. Product Picture of Diameter≥25mm
Figure 24. Global Colonic Stent Sales Market Share by Diameter in 2026
Figure 25. Global Colonic Stent Revenue Market Share by Diameter (2021-2026)
Figure 26. Colonic Stent Consumed in Malignant Colonic Stenosis and Obstruction
Figure 27. Global Colonic Stent Market: Malignant Colonic Stenosis and Obstruction (2021-2026) & (K Units)
Figure 28. Colonic Stent Consumed in Patient Treatment
Figure 29. Global Colonic Stent Market: Patient Treatment (2021-2026) & (K Units)
Figure 30. Colonic Stent Consumed in Preoperative Bridging Therapy
Figure 31. Global Colonic Stent Market: Preoperative Bridging Therapy (2021-2026) & (K Units)
Figure 32. Colonic Stent Consumed in Benign Colonic Stenosis
Figure 33. Global Colonic Stent Market: Benign Colonic Stenosis (2021-2026) & (K Units)
Figure 34. Colonic Stent Consumed in Other
Figure 35. Global Colonic Stent Market: Other (2021-2026) & (K Units)
Figure 36. Global Colonic Stent Sale Market Share by Application (2025)
Figure 37. Global Colonic Stent Revenue Market Share by Application in 2025
Figure 38. Colonic Stent Sales by Company in 2025 (K Units)
Figure 39. Global Colonic Stent Sales Market Share by Company in 2025
Figure 40. Colonic Stent Revenue by Company in 2025 ($ millions)
Figure 41. Global Colonic Stent Revenue Market Share by Company in 2025
Figure 42. Global Colonic Stent Sales Market Share by Geographic Region (2021-2026)
Figure 43. Global Colonic Stent Revenue Market Share by Geographic Region in 2025
Figure 44. Americas Colonic Stent Sales 2021-2026 (K Units)
Figure 45. Americas Colonic Stent Revenue 2021-2026 ($ millions)
Figure 46. APAC Colonic Stent Sales 2021-2026 (K Units)
Figure 47. APAC Colonic Stent Revenue 2021-2026 ($ millions)
Figure 48. Europe Colonic Stent Sales 2021-2026 (K Units)
Figure 49. Europe Colonic Stent Revenue 2021-2026 ($ millions)
Figure 50. Middle East & Africa Colonic Stent Sales 2021-2026 (K Units)
Figure 51. Middle East & Africa Colonic Stent Revenue 2021-2026 ($ millions)
Figure 52. Americas Colonic Stent Sales Market Share by Country in 2025
Figure 53. Americas Colonic Stent Revenue Market Share by Country (2021-2026)
Figure 54. Americas Colonic Stent Sales Market Share by Type (2021-2026)
Figure 55. Americas Colonic Stent Sales Market Share by Application (2021-2026)
Figure 56. United States Colonic Stent Revenue Growth 2021-2026 ($ millions)
Figure 57. Canada Colonic Stent Revenue Growth 2021-2026 ($ millions)
Figure 58. Mexico Colonic Stent Revenue Growth 2021-2026 ($ millions)
Figure 59. Brazil Colonic Stent Revenue Growth 2021-2026 ($ millions)
Figure 60. APAC Colonic Stent Sales Market Share by Region in 2025
Figure 61. APAC Colonic Stent Revenue Market Share by Region (2021-2026)
Figure 62. APAC Colonic Stent Sales Market Share by Type (2021-2026)
Figure 63. APAC Colonic Stent Sales Market Share by Application (2021-2026)
Figure 64. China Colonic Stent Revenue Growth 2021-2026 ($ millions)
Figure 65. Japan Colonic Stent Revenue Growth 2021-2026 ($ millions)
Figure 66. South Korea Colonic Stent Revenue Growth 2021-2026 ($ millions)
Figure 67. Southeast Asia Colonic Stent Revenue Growth 2021-2026 ($ millions)
Figure 68. India Colonic Stent Revenue Growth 2021-2026 ($ millions)
Figure 69. Australia Colonic Stent Revenue Growth 2021-2026 ($ millions)
Figure 70. China Taiwan Colonic Stent Revenue Growth 2021-2026 ($ millions)
Figure 71. Europe Colonic Stent Sales Market Share by Country in 2025
Figure 72. Europe Colonic Stent Revenue Market Share by Country (2021-2026)
Figure 73. Europe Colonic Stent Sales Market Share by Type (2021-2026)
Figure 74. Europe Colonic Stent Sales Market Share by Application (2021-2026)
Figure 75. Germany Colonic Stent Revenue Growth 2021-2026 ($ millions)
Figure 76. France Colonic Stent Revenue Growth 2021-2026 ($ millions)
Figure 77. UK Colonic Stent Revenue Growth 2021-2026 ($ millions)
Figure 78. Italy Colonic Stent Revenue Growth 2021-2026 ($ millions)
Figure 79. Russia Colonic Stent Revenue Growth 2021-2026 ($ millions)
Figure 80. Middle East & Africa Colonic Stent Sales Market Share by Country (2021-2026)
Figure 81. Middle East & Africa Colonic Stent Sales Market Share by Type (2021-2026)
Figure 82. Middle East & Africa Colonic Stent Sales Market Share by Application (2021-2026)
Figure 83. Egypt Colonic Stent Revenue Growth 2021-2026 ($ millions)
Figure 84. South Africa Colonic Stent Revenue Growth 2021-2026 ($ millions)
Figure 85. Israel Colonic Stent Revenue Growth 2021-2026 ($ millions)
Figure 86. Turkey Colonic Stent Revenue Growth 2021-2026 ($ millions)
Figure 87. GCC Countries Colonic Stent Revenue Growth 2021-2026 ($ millions)
Figure 88. Manufacturing Cost Structure Analysis of Colonic Stent in 2026
Figure 89. Manufacturing Process Analysis of Colonic Stent
Figure 90. Industry Chain Structure of Colonic Stent
Figure 91. Channels of Distribution
Figure 92. Global Colonic Stent Sales Market Forecast by Region (2027-2032)
Figure 93. Global Colonic Stent Revenue Market Share Forecast by Region (2027-2032)
Figure 94. Global Colonic Stent Sales Market Share Forecast by Type (2027-2032)
Figure 95. Global Colonic Stent Revenue Market Share Forecast by Type (2027-2032)
Figure 96. Global Colonic Stent Sales Market Share Forecast by Application (2027-2032)
Figure 97. Global Colonic Stent Revenue Market Share Forecast by Application (2027-2032)
More Publications
Global Spinal Surgical Devices Market Growth 2023-2029
US$ 3,660.00
February 2023
105 pages
Global Demineralized Bone Matrix (DBM) Market Growth 2025-2031
US$ 3,660.00
January 2025
93 pages
Global Medical Electrodes Market Growth 2025-2031
US$ 3,660.00
January 2025
163 pages
Global Electrocautery Devices Market Growth 2024-2030
US$ 3,660.00
March 2024
113 pages
